EDGEMOND JAMES bought UTHR
March 15, 2023 · Form 4 insider transaction
EDGEMOND JAMES bought 58,170 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1079 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,170
Price
$0.00
Total value
N/A
InsiderEDGEMOND JAMES
RoleOfficer
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateMarch 15, 2023
Filing dateFebruary 26, 2026
Shares owned after58,170
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These performance-based stock options were initially awarded on March 15, 2023, subject to a three-year performance condition tied to average cash profit margin during 2023-2025, which was determined on February 25, 2026. The number of stock options reported represents the number of options earned based on performance, all of which will vest on March 15, 2026.